HealthFlex
×
  • Home
  • About Us
    • The Company
    • Vision & Philosophy
  • Products
    • Brand Philosophy
    • Claricell® Essential
    • Claricell® Junior
    • Claricell® PerformX
    • Claricell® Active
  • Wellmune®
    • What is Wellmune®?
    • How does it work?
    • Scientific & clinical support
  • Our Immune System
    • About our Immune System
    • Two Immune Systems
  • Partners
    • Distributors
    • Suppliers
    • Informed Sport
  • Contact
  • English
  • Serbian
  • Hungarian

Wellmune® Children’s Study Published

Wellmune® Children’s Study Published
July 11, 2016

Baker’s Yeast Beta-Glucan Decreases Episodes of Common Childhood Illness in 1 to 4 Year Old Children during Cold Season in China

Infections are common in early childhood and create a large economic burden on both the healthcare system and individual family. To solve this problem, we evaluated the ability of baker’s yeast beta glucan (BYBG) to reduce the number of episodes of common childhood illness in 174 Chinese children with 1 to 4 years old in a 12 week randomized, double-blinded, placebo controlled study. We found that children in BYBG group experienced less common childhood infectious illness episodes during the study compared to the placebo group and BYBG were well tolerated for the children with 1 to 4 years old.

Download the published study

Copyright ©2016 all rights reserved - Bioconnect AS 997 194 149
Designed by Plethora Themes